Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -9.79M | -2.49M | 28.72M | -16.5M | -17.01M | -19.59M | -13.18M | -16.11M | -12.68M | -16.27M | -18.75M | -17.42M | -16.9M | -30M | -11.01M | -2.18M | -5.45M | 19.29M | -10.16M | -2.98M | 3.21M | -996K |
Depreciation & Amortization | 1.84M | 1.62M | -1.9M | 1.72M | 1.81M | 1.78M | 1.71M | 1.57M | 1.52M | 1.49M | 1.58M | 1.7M | 1.33M | 1.27M | 1.19M | 1.13M | 1.1M | 987K | 920K | 850K | 794K | 777K |
Stock-Based Compensation | 1.07M | 1.69M | -893K | 1.02M | 752K | 1.46M | 1.29M | 2.39M | 3.39M | 4.09M | 4.08M | 4.66M | 4.11M | 4.97M | 6.07M | 6.55M | 6.51M | 8.55M | 24.38M | 59K | 51K | 42K |
Other Working Capital | 4.74M | 3.86M | -2.72M | 528K | 1.97M | 1.33M | 5.75M | 3.16M | -2.94M | 5M | 2.82M | 731K | 3.04M | -406K | 841K | 2.15M | 3.05M | 1M | -10.37M | 1.18M | -3.87M | 488K |
Other Non-Cash Items | 4.52M | -3.95M | -30.38M | 7.3M | 7.54M | 8.23M | 1.64M | 1.51M | -1.09M | 1.63M | 2.89M | 3.78M | 1M | 13.12M | -4.59M | -11.81M | -12.76M | -37.99M | -28.1M | 73K | -5.89M | 18K |
Deferred Income Tax | n/a | n/a | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -126K | 80K | -4K | -26K | -446K | 52K | -49K | 180K | 2.3M | -3.76M | n/a | 221K |
Change in Working Capital | 14.3M | 928K | 7.65M | -6.17M | -3.29M | 3.13M | 12.73M | 11.46M | -3.41M | -2.73M | 6.45M | -1.11M | 1.8M | -4.78M | -5.22M | -7.6M | 271K | -7.99M | -12.68M | 3.08M | -5.29M | 402K |
Operating Cash Flow | 11.94M | -2.22M | 3.23M | -12.63M | -10.2M | -4.99M | 4.19M | 819K | -15.66M | -15.88M | -3.89M | -8.31M | -8.66M | -15.45M | -14M | -20.4M | -10.38M | -16.98M | -23.34M | -2.68M | -7.13M | 464K |
Capital Expenditures | -908K | -1.04M | -1.06M | -604K | -1.21M | -328K | -1.76M | 402K | -1.83M | -610K | -861K | -930K | -937K | -1.84M | -2M | -1.19M | -1.34M | -1M | -871K | -950K | -607K | -619K |
Cash Acquisitions | n/a | n/a | -126K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -156K | n/a | n/a | n/a | -470K | 813K | -8.92M | n/a | -8.28M | n/a | n/a | -827K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 88K | 64K | 12K | -9.76M | -30.11M | -87.4M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | 20M | 20M | 12.56M | 8.58M | 30.13M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -1.08M | n/a | n/a | 126K | n/a | n/a | n/a | n/a | n/a | n/a | -4.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -200K | n/a |
Investing Cash Flow | -908K | -1.04M | -1.06M | -604K | -1.21M | -202K | -1.76M | 10.4M | 18.18M | 19.39M | 11.63M | 7.71M | 24.9M | 18.4M | -32.57M | -87.78M | -10.26M | -1M | -9.15M | -950K | -607K | -1.45M |
Debt Repayment | 26K | -9K | -9K | -8K | -10K | -20.01M | -10K | -11K | -9K | -9K | -10K | -10K | -63K | -18K | -19K | 102.59M | -13K | -13K | -5.13M | -8K | -4.51M | 2.4M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -125K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -334K | -260K | -350K | 656K | -230K | -89K | -154K | -232K | -2.14M | -1M | -1.77M | -621K | -2.54M | -1.69M | -412K | 2.73M | -2.01M | -1.64M | 141.26M | n/a | 20M | 20M |
Financial Cash Flow | -218K | -28K | 3.73M | 10.6M | 1.96M | -4.74M | -164K | -243K | -2.15M | -938K | -1.78M | -756K | -2.6M | -1.71M | -847K | 105.4M | -10.69M | -1.66M | 136.13M | -8K | -4.51M | 22.4M |
Net Cash Flow | 10.81M | -3.29M | 5.91M | -2.63M | -9.45M | -9.93M | 2.27M | 10.98M | 369K | 2.57M | 5.95M | -1.36M | 13.64M | 1.24M | -47.42M | -2.78M | -31.33M | -19.64M | 103.64M | -3.64M | -12.24M | 21.41M |
Free Cash Flow | 11.03M | -3.26M | 2.17M | -13.23M | -11.41M | -5.32M | 2.43M | 1.22M | -17.49M | -16.49M | -4.75M | -9.24M | -9.6M | -17.29M | -15.99M | -21.59M | -11.72M | -17.98M | -24.21M | -3.63M | -7.74M | -155K |
Adj. Free Cash Flow | 9.96M | -4.94M | 3.07M | -14.26M | -12.16M | -6.77M | 1.14M | -1.17M | -20.87M | -20.58M | -8.83M | -13.9M | -13.7M | -22.26M | -22.06M | -28.14M | -18.24M | -26.54M | -48.59M | -3.69M | -7.79M | -197K |
Maintenance CapEx | -908K | -1.04M | n/a | n/a | n/a | n/a | -700.93K | 804K | -489.83K | n/a | n/a | n/a | n/a | -461.47K | -1.14M | -620.32K | -845.2K | -706.84K | -831.24K | -890.15K | -576.46K | -564.69K |
Growth CapEx | n/a | n/a | -1.06M | -604K | -1.21M | -328K | -1.05M | -402K | -1.34M | -610K | -861K | -930K | -937K | -1.38M | -857.53K | -569.69K | -496.8K | -295.16K | -39.76K | -59.85K | -30.54K | -54.31K |
Owner Earnings | 11.03M | -3.26M | 3.23M | -12.63M | -10.2M | -4.99M | 3.49M | 1.62M | -16.15M | -15.88M | -3.89M | -8.31M | -8.66M | -15.91M | -15.13M | -21.02M | -11.22M | -17.69M | -24.17M | -3.57M | -7.71M | -100.69K |
Add to Watchlist
Select watchlists to add or remove TOI